MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy

Clinical trial NCT03452345 · COMPLETED

Trial details

NCT number: NCT03452345
Sponsor: Medy-Tox
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Masseter Muscle Hypertrophy

Start date: 2018-04-09
Primary completion: 2019-01-31
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.